Agenus Announces Three BOT+BAL Presentations Spanning Neoadjuvant and Late-Line Colorectal Cancer and Advanced Sarcomas at ESMO 2026
Go back to Agenus Announces Three BOT+BAL Presentations Spanning Neoadjuvant and Late-Line Colorectal Cancer and Advanced Sarcomas at ESMO 2026| AGENUS (NASDAQ: AGEN) | Delayed: 8.68 +0.35 (4.20%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.33 | 52 Week High | $7.49 | |||
| Open | $8.26 | 52 Week Low | $2.61 | |||
| Day High | $8.74 | P/E | N/A | |||
| Day Low | $8.16 | EPS | $-1.10 | |||
| Volume | 314,683 | |||||

